## Background: Although experimental studies have demonstrated an important role of insulin-like growth factor i (igf-i) in hepatocarcinogenesis, the clinical data about igf-i in patients with hepatocellular carcinoma (hcc) are scarce and controversial. to the authors' knowledge, this is the first
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis
✍ Scribed by F. AZZAROLI; A. COLECCHI; F. LODATO; D. TRERÈ; M. L. BACCHI REGGIANI; D. FESTI; G. M. PRATI; E. ACCOGLI; S. CASANOVA; M. DERENZINI; E. RODA; G. MAZZELLA
- Book ID
- 108604594
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 211 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
In Japan, hepatocellular carcinoma (HCC) is one of the most prevalent cancers, with a reported fatality rate showing a consistent and significant increase in the last decade. At most, only 25% of HCC cases are positive for the hepatitis B surface antigen (HBsAg). To investigate a potential role for
Many studies have demonstrated in animal experiments that persistent inflammation may accelerate the development of carcinoma. In this article, the question of whether the persistent elevation of serum alanine aminotransferase (ALT) levels (which represents the inflammatory necrosis of hepatocytes)